Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Liquidia Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Liquidia Corporation June 20, 202498.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Evommune Inc. | Open-market purchase | +10,000 | $13.30 | $133,000 |
| Jun 16, 2026 | Liquidia Corporation | Grant or award | +5,882 | — | — |
| Jun 3, 2026 | Liquidia Corporation | Open-market sale | −10,000 | $54.80 | $548,000 |
| Jun 2, 2026 | Liquidia Corporation | Open-market sale | −5,000 | $56.00 | $280,000 |
| Jun 1, 2026 | Liquidia Corporation | Open-market sale | −15,000 | $60.22 | $903,300 |
| Jun 17, 2025 | Liquidia Corporation | Grant or award | +18,396 | — | — |
| Jun 20, 2024 | Liquidia Corporation | Grant or award | +20,359 | — | — |
Questions about Arthur S. Kirsch
What boards is Arthur S. Kirsch on?
Arthur S. Kirsch sits on the boards of Atea Pharmaceuticals Inc., Evommune Inc. and Liquidia Corporation.
How long has Arthur S. Kirsch served on boards?
Our records show at least 6 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.